Lifestyle Intervention With an Interactive Video Game for Type 2 Diabetes Patients

NCT ID: NCT01735643

Last Updated: 2012-11-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

EARLY_PHASE1

Total Enrollment

220 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-01-31

Study Completion Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Due to overweight and unhealthy lifestyle the number of patients with type 2 diabetes mellitus is increasing. Although in early phases the disease might be successfully treated by lifestyle change patients lack for motivation. Instead of increasing anti-diabetic medication a highly motivational system with low inhibition threshold is needed. Therefore, the investigators analyzed if regular use of the interactive videogame Wii Fit Plus over 12 weeks is able to improve HbA1c and weight in patients with type 2 diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with type 2 diabetes were recruited via treating physicians or articles in magazines and newspapers. Participants were randomized in an intervention and a control group. The intervention group was sent the Wii, the balance board and the interactive video game Wii Fit Plus and were instructed to use these items 30 minutes each day during the next 12 weeks. The control group got the items 12 weeks later. At begin and after 12 weeks of intervention participants (and additionally for the control group: after 12 weeks of waiting phase) sent their health parameters, which had been measured in the context of the disease management program type 2 diabetes as well as questionnaires about physical activity and quality of life to the study center.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Mellitus

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

type 2 diabetes mellitus physical activity lifestyle change motivation patient empowerment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

interactive videogame intervention

Group Type EXPERIMENTAL

interactive videogame Wii Fit Plus

Intervention Type DEVICE

Use of the interactive videogame Wii Fit Plus für 12 weeks.

waiting group

Group Type EXPERIMENTAL

waiting

Intervention Type OTHER

waiting for 12 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

interactive videogame Wii Fit Plus

Use of the interactive videogame Wii Fit Plus für 12 weeks.

Intervention Type DEVICE

waiting

waiting for 12 weeks

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Wii Fit Plus

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* type 2 diabetes mellitus
* diabetes duration \< 5 years
* age 50-75 years
* body mass index \> or equal to 27 kg/m2
* participating in the disease management programme type 2 diabetes mellitus
* physical and mental able for study participation

Exclusion Criteria

* insulin or antidiabetic medication (exception: Metformin and DPP-IV-Inhibitors)
* regular physical activity
* depression
* tumors
* change of smoking status during the past 6 months or during the study
* participation in other studies during the past 6 months
Minimum Eligible Age

50 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Novartis Pharmaceuticals

INDUSTRY

Sponsor Role collaborator

Nintendo of Europe GmbH

UNKNOWN

Sponsor Role collaborator

West German Center of Diabetes and Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stephan Martin

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stephan Martin, MD

Role: PRINCIPAL_INVESTIGATOR

West German Center of Diabetes and Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

West German Center of Diabetes and Health

Düsseldorf, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Kempf K, Martin S. Autonomous exercise game use improves metabolic control and quality of life in type 2 diabetes patients - a randomized controlled trial. BMC Endocr Disord. 2013 Dec 10;13:57. doi: 10.1186/1472-6823-13-57.

Reference Type DERIVED
PMID: 24321337 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.vkkd-kliniken.de

Affiliation homepage

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Wii study

Identifier Type: -

Identifier Source: org_study_id